TrialScope

Data Transparency Platform for Clinical Trials

Harborside Financial Center, Plaza Five, Suite 2900, Jersey City, 07311,New Jersey, United States of America

Harborside Financial Center, Plaza Five, Suite 2900, Jersey City, 07311,New Jersey, United States of America



TrialScope is a clinical trial management platform that ensures compliance processes are consistently implemented while optimising disclosure activities and trial data transparency.

This flexible and customisable platform is designed to inform and engage patients through open research sharing. It supports clinical trial disclosure and transparency, from registration to final report summaries.

TrialScope improves patient recruitment and engagement, as well as promotes simplified and validated data-sharing across all of its corporate websites. The platform is intuitive, easy-to-use, and connects data in real-time, which ensures that trial information is promptly displayed for both internal and public viewing.

TrialScope is currently used in 40% of industry trials registered on ClinicalTrials.gov and EudraCT. Today, more than 12,000 users manage more than 30,000 clinical trials using TrialScope’s technologies.

Clinical trial disclosure and registration software

TrialScope DiscloseTM centralises, tracks and registers clinical trial data in compliance with disclosure processes. The system mitigates compliance risks and provides greater control over disclosure reputation.

The platform’s comprehensive, Cloud-based software includes a full range of capabilities for compliant, confident clinical trial disclosure, from protocol to registration to results.

Turnkey clinical trials website solution for patients

TrialScope EngageTM enables clinical trial sponsors to engage with patients and the public via a user-friendly, high-impact website.

The site openly shares clinical trial information and results, demonstrating leadership in transparency. It also optimises recruitment and patient retention.

TrialScope Engage enables sponsors to deliver clear communications via the clinical trial publication website, and ensuring only pre-approved and accurate trial information is shared using real-time connectivity to ClinicalTrials.gov and TrialScope Disclose platforms.

Disclosure advisory services for data-driven evaluation

TrialScope is one of the most widely used global clinical trial disclosure and transparency management platforms in the world. It offers disclosure services that can be used in conjunction with the platform’s state-of-the-art software to make disclosure efforts more accurate and efficient.

The services are scalable, so clients can adjust the parameters to accommodate their changing workload.

Utilising an established, data-driven evaluation methodology, TrialScope’s advisory services provide clinical trial sponsors with vital disclosure and transparency reviews and recommendations. These prepare sponsors for pending inspections and help improve assessment results.

TrialScope’s experts offer concrete metrics and best practice recommendations to achieve compliant, efficient clinical trial disclosure that also meets evolving transparency trends.

TrialScope Disclose

TrialScope DiscloseTM delivers the proven solutions clinical trial sponsors need to centralise, track, register and comply with clinical trial disclosure processes, mitigating compliance risks while giving them greater control over their own clinical trial disclosure reputation.

TrialScope Engage

TrialScope EngageTM enables clinical trial sponsors to engage with patients and the public via a user-friendly, high-impact website to openly share clinical trial information and results, demonstrating leadership in transparency while optimizing trial recruitment and retention.

Disclosure as a Service

TrialScope is more than just one of the most widely used global clinical trial disclosure and transparency management platforms. It also offers disclosure services that, when used in conjunction with its state-of-the-art software, makes your disclosure efforts more accurate and efficient than ever before. TrialScope’s services are scalable, so you can adjust to accommodate your changing workload.

Disclosure Advisory Services

Utilising an established, data-driven evaluation methodology, TrialScope's advisory services provides clinical trial sponsors with vital disclosure and transparency reviews and recommendations that not only prepare sponsors for pending inspections but also help them improve ranking in assessments by transparency advocates.

TrialScope Announces Opening of New Headquarters

TrialScope has announced it has relocated its headquarters to a larger space that accommodates the rapid growth the company has experienced and the expected growth in the next few years.

TrialScope Announces Executive Appointments

TrialScope has announced two executive appointments. Brian Flaherty will be vice-president of Business Development and Thomas Wicks has been appointed chief strategy officer (CSO).

TrialScope, Inc

Harborside Five

185 Hudson Street, Suite 2900

Jersey City, NJ 07311

07311

New Jersey

United States of America

+1 877 658 8310 www.trialscope.com
TrialScope

Harborside Financial Center

Plaza Five, Suite 2900

Jersey City

07311

New Jersey

United States of America

www.trialscope.com